Logo of National Resource Center on AD/HD
Home · Register · NRC Library    in Spanish
Ask a Question About AD/HD

ADHD in the News - December 15, 2011
Become an NRC fan on Facebook

Can't find what you're looking for? Our health information specialists are here to help. Contact us at 800-233-4050 or online.

ADHD in the News - December 15, 2011

A weekly news digest** from the National Resource Center on ADHD: A Program of CHADD

  1. Studies Could Ease Fears of Medicines for ADHD (Wall Street Journal, December 13, 2011)

    Ritalin, Adderall and other drugs widely used to treat attention disorders didn't increase the risk of serious heart problems in a major study published Monday that could help ease concerns about the heart-related safety of the medicines. The findings, from an analysis involving nearly 500,000 adults, come on the heels of a separate study that reached a similar conclusion about the medications' effect in 1.2 million children and young adults. Full Story

  2. New Evidence Addresses ADHD Meds and Adult CVD Risk (Medscape Medical News, December 12, 2011)

    Stimulants and other medications used to treat attention-deficit hyperactivity disorder (ADHD) confer no increased risk for serious cardiovascular events, according to a study published online December 12 in the Journal of the American Medical Association. "This is one of the first studies, and the largest in adults, to examine the cardiovascular safety of ADHD medications," first author Laurel A. Habel, PhD, of the Division of Research, Kaiser Permanente Northern California, Oakland, told Medscape Medical News. Full Story

  3. Mental Disorders Common, Persistent in US Adolescents (Medscape Medical News, December 9, 2011)

    "New data from a national survey confirm that mental health disorders are "highly prevalent and persistent" in adolescents in the United States and that most adult mental disorders first present in childhood and adolescence. These findings "provide a strong rationale for continuing to prioritize research to understand the development of major mental disorders during the first 2 decades of life," Ronald C. Kessler, PhD, from the Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, and colleagues conclude. The report was published online December 5 in the Archives of General Psychiatry..." Full Story

  4. Movie to tell story of Torres' ADHD struggles (Boston, December 15, 2011)

    "NEW YORK-New Mets center fielder Andres Torres knows about struggles. An injury-plagued 2011 season was difficult. But he's dealt with greater adversity. A new documentary is coming out on how he managed his Attention Deficit Hyperactivity Disorder to become a World Series winner with the San Francisco Giants in 2010..." Full Story

  5. The Sachs Center, New York City's Premiere Attention Deficit Disorder (ADD) Treatment Center, Now Offers Organizational Coaching for Adults with ADD (PRWeb, December 14, 2011)

    "Organizational skills are a vital component to a happy and successful life. Most people with ADD have added difficulties with organization, often because they fear they won't become perfectly organized. For those in need of support to become more organized, The Sachs Center in Manhattan has announced new therapy services for adults with ADD who struggle with organizational difficulties. In commemoration of this new service, Dr. George Sachs offers these 10 Organizational Tips..." Full Story

  6. Shire Readies Europe for First Dose of Amphetamine (Medscape Today, December 12, 2011)

    "Shire has treated a generation of American children who can't concentrate, using amphetamine-based stimulants. As recognition of attention deficit disorder grows in Europe, the company believes it can overcome skepticism about the treatment to sell it here too. The UK specialized drug company will file for European approval of Vyvanse, its next-generation medicine for attention deficit hyperactivity disorder (ADHD) by the end of the year..." Full Story

  7. The Surprising Economic Burden of ADHD (Attention-Deficit Hyperactivity Disorder) (Better Health, December 14, 2011)

    "It is estimated that as many as 10 million U.S. adults have ADHD (Attention-Deficit/Hyperactivity Disorder). A recent research study (publication-pending) suggests that the economic burden of ADHD on America could be as high as $250 billion annually. I attended a recent briefing on Capitol Hill and interviewed one of the study's co-authors: Tufts economist, Dr. Peter Neumann as well as congressman (and psychologist) Tim Murphy about ADHD in America..." Full Story

  8. ADHD research exploding in recent months (eMaxhealth.com, December 13, 2011)

    "In recent months, researchers have published a large amount of material regarding attention deficit hyperactivity disorder (ADHD)...Amphetamine (Adderall), methylphenidate (Ritalin) and other central nervous system stimulants are given to children who suffer from ADHD. Interestingly, these drugs do not have the stimulant effect observed in adults when given to children before they reach puberty. In the U.S., approximately 2.7 million children are prescribed ADHD medication, primarily to reduce impulsive behavior as well as to improve focus and attention span. In addition, more than 1.5 million adults also take the medications. Over the past decade, the use of ADHD drugs in adults has outpaced that in children..." Full Story

**Disclaimer: Neither CHADD, the National Resource Center on ADHD, nor the Centers for Disease Control and Prevention endorses, supports, represents or guarantees the truthfulness, accuracy, or reliability of any included articles nor endorses any opinions expressed in any articles included in ADHD in the News. CHADD and the National Resource Center on ADHD merely provide access to such content as a service to you.

ADHD in the News - Archive

Frequently Asked Questions
What is Executive Function?
Can you help me find a doctor or mental health professional?
Is there a simple test to diagnose ADHD?
What is Section 504?
If I request an evaluation, doesn't the school have to do it?
View all Frequently Asked Questions

Ask a question about AD/HD

Print Page · Email Page · About Us · Contact Us
Terms of Use · Privacy Policy · Site Map